NCT00379990View on ClinicalTrials.gov

A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

GW274150

60 mg /day

DRUG

Prednisolone

7.5 mg/day

OTHER

Placebo

Placebo

Trial Locations (2)

11000

GSK Investigational Site, Belgrade

W6 8LH

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00379990 - A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. | Biotech Hunter | Biotech Hunter